BioNTech SE (BNTX)
Health Care
BNTX is listed on Nasdaq, where its shares have traded since October 10, 2019. It represents shares of BioNTech SE, which reports its financial results in EUR. SentiSense covers it in the Health Care sector.
About BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens and neoantigens; monospecific and bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.
Latest reported results
BioNTech SE reported revenue of 105.6 million EUR for Q2 FY2026, down 59.5% from the same period a year earlier.
Institutional ownership
In 13F filings for the quarter ended June 30, 2026, 278 institutions reported holding BNTX, with 46.7 million shares worth $4.3 billion in aggregate. The largest reported holders were FMR, Primecap Management Co and Dodge & Cox. Of the 5 largest reported holders, 2 added shares and 3 reduced their positions during the quarter.
More on BNTX
- BNTX sentiment: whether news and social coverage of BioNTech SE leans bullish or bearish, and the stories driving it.
- BNTX ownership: all 278 reporting institutions, plus insider and congressional trades.
- BNTX financials: revenue, net income, operating margin and free cash flow through Q2 FY2026.
SentiSense also tracks daily options readings for BioNTech SE: IV rank, put/call percentile, 25-delta skew and open-interest walls.
Frequently asked questions
What does BioNTech SE do?
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid.
What sector is BNTX in?
SentiSense classifies BioNTech SE in the Health Care sector.
Where does BNTX stock trade?
BNTX is listed on Nasdaq, where its shares have traded since October 10, 2019. It represents shares of BioNTech SE, which reports its financial results in EUR.
Who is the CEO of BioNTech SE?
Ugur Sahin is the chief executive officer of BioNTech SE.